Retrospective analysis of lung cancer patients treated with supportive care alone

被引:3
作者
Ashinuma, Hironori [1 ]
Shingyoji, Masato [1 ]
Yoshida, Yasushi [1 ]
Itakura, Meiji [1 ]
Iizasa, Toshihiko [2 ]
Sakashita, Yoshihiko [3 ]
Sekine, Ikuo [1 ,4 ]
机构
[1] Chiba Canc Ctr, Div Resp Med, Chuo Ku, 666-2 Nitonacho, Chiba, Chiba 2608717, Japan
[2] Chiba Canc Ctr, Div Thorac Surg, Chiba, Japan
[3] Chiba Canc Ctr, Div Palliat Care, Chiba, Japan
[4] Univ Tsukuba, Fac Med, Dept Med Oncol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan
关键词
Lung cancer; Supportive care; Palliative therapy; Home care; Palliative care unit; OF-LIFE CARE; SURVIVAL; POPULATION; PLACE; HOME; CHEMOTHERAPY; PATTERNS; COMORBIDITY; COHORT; IMPACT;
D O I
10.1007/s10147-017-1094-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background It is not uncommon for patients with lung cancer to receive supportive care alone. However, the clinical characteristics of these patients have not been fully studied. We conducted a retrospective study to identify the clinical characteristics of definitive lung cancer patients treated with supportive care alone. Methods We retrospectively analyzed the percentage of and reasons for definitive lung cancer patients treated with supportive care alone at a regional cancer center. We also investigated the histological diagnostic approaches, palliative therapy types, primary treatment locations after hospital consultation, and places of death. Results A total of 1,223 patients were histologically diagnosed as having lung cancer between 2011 and 2014. Of these, 160 (13%) patients were treated with supportive care alone. The primary reason for treatment with supportive care alone was a poor performance status (PS) in almost half of the patients. Overall, 40% of the patients received supportive care at home, and 17% were admitted to a palliative care unit (PCU). Death occurred at home for 17% of the patients and in the PCU for 42% of the patients. Conclusion This study revealed that 13% of histologically proven lung cancer patients were treated with supportive care alone, mostly because of a poor PS. Only 40% of these patients received home care, suggesting the need for a more accessible home care system for patients and their families.
引用
收藏
页码:455 / 460
页数:6
相关论文
共 24 条
[1]   Treatment of non-small cell lung cancer patients with performance status2 (PS2) [J].
Boukovinas, Ioannis ;
Kosmidis, Paris .
LUNG CANCER, 2009, 63 (01) :10-15
[2]   Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not [J].
Brute, Stephanie Y. ;
Al-Baimani, Khalid ;
Jonker, Hannah ;
Zhang, Tinghua ;
Nicholas, Garth ;
Goss, Glenwood ;
Laurie, Scott A. ;
Wheatley-Price, Paul .
LUNG CANCER, 2016, 97 :15-21
[3]   Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer [J].
Edwards, Brenda K. ;
Noone, Anne-Michelle ;
Mariotto, Angela B. ;
Simard, Edgar P. ;
Boscoe, Francis P. ;
Henley, S. Jane ;
Jemal, Ahmedin ;
Cho, Hyunsoon ;
Anderson, Robert N. ;
Kohler, Betsy A. ;
Eheman, Christie R. ;
Ward, Elizabeth M. .
CANCER, 2014, 120 (09) :1290-1314
[4]   Associations with the Japanese Population's Preferences for the Place of End-of-Life Care and Their Need for Receiving Health Care Services [J].
Fukui, Sakiko ;
Yoshiuchi, Kazuhiro .
JOURNAL OF PALLIATIVE MEDICINE, 2012, 15 (10) :1106-1112
[5]   Japanese People's Preference for Place of End-of-Life Care and Death: A Population-Based Nationwide Survey [J].
Fukui, Sakiko ;
Yoshiuchi, Kazuhiro ;
Fujita, Junko ;
Sawai, Minako ;
Watanabe, Minako .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2011, 42 (06) :882-892
[6]   Referral and Treatment Patterns Among Patients With Stages III and IV Non-Small-Cell Lung Cancer [J].
Goulart, Bernardo H. L. ;
Reyes, Carolina M. ;
Fedorenko, Catherine R. ;
Mummy, David G. ;
Satram-Hoang, Sacha ;
Koepl, Lisel M. ;
Blough, David K. ;
Ramsey, Scott D. .
JOURNAL OF ONCOLOGY PRACTICE, 2013, 9 (01) :42-+
[7]   Multicenter cohort study on the survival time of cancer patients dying at home or in a hospital: Does place matter? [J].
Hamano, Jun ;
Yamaguchi, Takashi ;
Maeda, Isseki ;
Suga, Akihiko ;
Hisanaga, Takayuki ;
Ishihara, Tatsuhiko ;
Iwashita, Tomoyuki ;
Kaneishi, Keisuke ;
Kawagoe, Shohei ;
Kuriyama, Toshiyuki ;
Maeda, Takashi ;
Mori, Ichiro ;
Nakajima, Nobuhisa ;
Nishi, Tomohiro ;
Sakurai, Hiroki ;
Shimoyama, Satofumi ;
Shinjo, Takuya ;
Shirayama, Hiroto ;
Yamada, Takeshi ;
Morita, Tatsuya .
CANCER, 2016, 122 (09) :1453-1460
[8]   Comorbidity and Survival in Lung Cancer Patients [J].
Islam, K. M. Monirul ;
Jiang, Xiaqing ;
Anggondowati, Trisari ;
Lin, Ge ;
Ganti, Apar Kishor .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (07) :1079-1085
[9]   What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?-Results from the lung cancer economics and outcomes research (LUCEOR) study [J].
Lester, J. F. ;
Agulnik, J. ;
Akerborg, O. ;
Chouaid, C. ;
De Geer, A. ;
Finnern, H. W. ;
Herder, G. J. M. ;
Lungershausen, J. ;
Mitchell, P. L. R. ;
Vansteenkiste, J. ;
Ziske, C. ;
Goker, E. .
LUNG CANCER, 2013, 82 (01) :128-135
[10]  
MCCORKLE R, 1989, CANCER-AM CANCER SOC, V64, P1375, DOI 10.1002/1097-0142(19890915)64:6<1375::AID-CNCR2820640634>3.0.CO